Nutex Health (NUTX) EBIT Margin: 2009-2024
Historic EBIT Margin for Nutex Health (NUTX) over the last 15 years, with FY2024 value amounting to 27.23%.
- Nutex Health's EBIT Margin rose 364200.0% to 48.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.58%, marking a year-over-year increase of 399100.0%. This contributed to the annual value of 27.23% for FY2024, which is 400600.0% up from last year.
- According to the latest figures from FY2024, Nutex Health's EBIT Margin is 27.23%, which was up 400600.0% from 12.83% recorded in FY2023.
- In the past 5 years, Nutex Health's EBIT Margin ranged from a high of 55.9% in FY2020 and a low of 185.41% during FY2022
- Over the past 5 years, Nutex Health's median EBIT Margin value was 27.23% (recorded in 2024), while the average stood at 12.75%.
- Its EBIT Margin has fluctuated over the past 5 years, first soared by 5607100bps in 2020, then tumbled by -2367700bps in 2022.
- Over the past 5 years, Nutex Health's EBIT Margin (Annual) stood at 55.9% in 2020, then fell by -8bps to 51.36% in 2021, then plummeted by -461bps to 185.41% in 2022, then surged by 93bps to 12.83% in 2023, then surged by 312bps to 27.23% in 2024.
- Its last three reported values are 27.23% in FY2024, 12.83% for FY2023, and 185.41% during FY2022.